Global Cholesterol Testing Products and Services Market Size study, By Product, By Test, By Age Group, By Application, By Service Provider and Regional Forecasts 2022-2032

Description

The global cholesterol testing products and services market was valued at USD 19.70 billion in 2024 and is projected to grow at a robust compound annual growth rate (CAGR) of 8.4% during the forecast period 2024-2032.

This growth is attributed to an increasing emphasis on preventive healthcare, rising incidences of cardiovascular diseases (CVDs), and significant advancements in diagnostic technologies.

Cholesterol testing products and services play a vital role in detecting and managing hyperlipidemia and related diseases. Home-based testing kits and advanced point-of-care devices are transforming the diagnostic landscape by offering consumers greater accessibility and convenience. In addition, non-fasting cholesterol tests and multi-use testing strips enhance patient compliance, broadening the market appeal. Organizations like the CDC recommend routine cholesterol screenings every four to six years for adults at risk of coronary heart disease, underscoring the importance of early diagnosis.

Emerging economies in the Asia-Pacific region are experiencing the fastest growth due to rising health awareness, evolving dietary patterns, and increasing urbanization. Furthermore, regulatory support and government initiatives, coupled with investments in healthcare infrastructure, are accelerating the market expansion. The aging global population is also a key driver, with individuals aged 60 and above forming a growing demographic demanding frequent cholesterol monitoring. In contrast, North America dominated the market in 2024, leveraging its advanced healthcare infrastructure and extensive health awareness campaigns.

However, challenges such as the high costs of advanced cholesterol testing systems and limited awareness in certain regions could hinder market growth. Nonetheless, innovative solutions like affordable testing kits and enhanced public health initiatives create significant opportunities for market players.

The competitive landscape of the cholesterol testing market is shaped by strategic collaborations, technological advancements, and mergers and acquisitions aimed at expanding product portfolios and enhancing testing accuracy. Companies are increasingly focusing on R&D investments to introduce innovative testing solutions that meet the demands of diverse populations.

Major market players included in this report are:

Quest Diagnostics Incorporated
Eurofins Scientific
Spectra Laboratories, Inc. (Fresenius Medical Care)
Novartis AG
Cell Biolabs, Inc.
Randox Laboratories Ltd.
SYNLAB AG
BioReference Health, LLC
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
Clinical Reference Laboratory, Inc.
Elabscience Bionovation Inc.
Abbott Laboratories
Roche Diagnostics
Verichem Laboratories

The detailed segments and sub-segments of the market are explained below:

By Product

Testing Kits
Testing Strips
Others

By Test

Total Cholesterol Tests
High-Density Lipoprotein (HDL) Cholesterol Tests
Low-Density Lipoprotein (LDL) Cholesterol Tests
Triglyceride Tests
Others

By Age Group

Geriatric
Adult
Pediatric

By Application

Cardiovascular Diseases
Obesity
Diabetes
Hyperlipidemia
Others

By Service Provider

Hospitals and Clinics
Diagnostic Laboratories
Ambulatory Care Centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of the geographical landscape with country-level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand-side and supply-side analysis of the market.

Chapter 1. Global Cholesterol Testing Products and Services Market Executive Summary

1.1. Global Cholesterol Testing Products and Services Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Test
- 1.3.3. By Application
- 1.3.4. By Service Provider
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Cholesterol Testing Products and Services Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Cholesterol Testing Products and Services Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising prevalence of cardiovascular diseases and obesity
- 3.1.2. Growing adoption of preventive healthcare measures
- 3.1.3. Technological innovations in testing devices and methods
3.2. Market Challenges
- 3.2.1. High costs of advanced cholesterol testing systems
- 3.2.2. Limited awareness in rural and emerging markets
3.3. Market Opportunities
- 3.3.1. Expansion into underserved regions
- 3.3.2. Development of home-based testing kits

Chapter 4. Global Cholesterol Testing Products and Services Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Cholesterol Testing Products and Services Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Cholesterol Testing Products and Services Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Testing Kits
- 5.2.2. Testing Strips
- 5.2.3. Others

Chapter 6. Global Cholesterol Testing Products and Services Market Size & Forecasts by Test 2022-2032

6.1. Segment Dashboard
6.2. Global Cholesterol Testing Products and Services Market: Test Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Total Cholesterol Tests
- 6.2.2. HDL Cholesterol Tests
- 6.2.3. LDL Cholesterol Tests
- 6.2.4. Triglyceride Tests
- 6.2.5. Others

Chapter 7. Global Cholesterol Testing Products and Services Market Size & Forecasts by Age Group 2022-2032

7.1. Segment Dashboard
7.2. Global Cholesterol Testing Products and Services Market: Age Group Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Geriatric
- 7.2.2. Adult
- 7.2.3. Pediatric

Chapter 8. Global Cholesterol Testing Products and Services Market Size & Forecasts by Application 2022-2032

8.1. Segment Dashboard
8.2. Global Cholesterol Testing Products and Services Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 8.2.1. Cardiovascular Diseases
- 8.2.2. Obesity
- 8.2.3. Diabetes
- 8.2.4. Hyperlipidemia
- 8.2.5. Others

Chapter 9. Global Cholesterol Testing Products and Services Market Size & Forecasts by Service Provider 2022-2032

9.1. Segment Dashboard
9.2. Global Cholesterol Testing Products and Services Market: Service Provider Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 9.2.1. Hospitals and Clinics
- 9.2.2. Diagnostic Laboratories
- 9.2.3. Ambulatory Care Centers
- 9.2.4. Others

Chapter 10. Global Cholesterol Testing Products and Services Market Size & Forecasts by Region 2022-2032

10.1. North America Cholesterol Testing Products and Services Market
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Mexico
10.2. Europe Cholesterol Testing Products and Services Market
- 10.2.1. UK
- 10.2.2. Germany
- 10.2.3. France
- 10.2.4. Italy
- 10.2.5. Spain
- 10.2.6. Denmark
- 10.2.7. Sweden
- 10.2.8. Norway
- 10.2.9. Rest of Europe
10.3. Asia Pacific Cholesterol Testing Products and Services Market
- 10.3.1. Japan
- 10.3.2. China
- 10.3.3. India
- 10.3.4. Australia
- 10.3.5. South Korea
- 10.3.6. Thailand
- 10.3.7. Rest of Asia Pacific
10.4. Latin America Cholesterol Testing Products and Services Market
- 10.4.1. Brazil
- 10.4.2. Argentina
- 10.4.3. Rest of Latin America
10.5. Middle East & Africa Cholesterol Testing Products and Services Market
- 10.5.1. South Africa
- 10.5.2. Saudi Arabia
- 10.5.3. UAE
- 10.5.4. Kuwait
- 10.5.5. Rest of Middle East & Africa

Chapter 11. Competitive Intelligence

11.1. Key Company SWOT Analysis
- 11.1.1. Quest Diagnostics Incorporated
- 11.1.2. Eurofins Scientific
- 11.1.3. Novartis AG
11.2. Top Market Strategies
11.3. Company Profiles
- 11.3.1. Spectra Laboratories, Inc.
- 11.3.2. Laboratory Corporation of America Holdings
- 11.3.3. Thermo Fisher Scientific Inc.

... (list continues up to 15 companies)

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes